Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Transaction Update

23 Jul 2020 12:00

RNS Number : 9141T
Marston's PLC
23 July 2020
 

FOR IMMEDIATE RELEASE

MARSTON'S PLC

Transaction Update

23 July 2020

As previously announced, Marston's PLC ("the Group") anticipated completion of the proposed arrangements with Carlsberg UK Holdings Limited ("the Transaction"), as described in the circular to shareholders dated 8 June 2020, to occur in Q3 of this calendar year, following shareholder approval and competition authority clearance.

We have been advised that for procedural reasons, the UK CMA (rather than the European Commission) will now likely be the relevant competition authority. As a result, completion is now anticipated to take place slightly later than expected as the CMA completes its review. Completion is now expected in Q4.

As stated previously, we do not expect that the Transaction raises any competition concerns and are satisfied that the Group has sufficient liquidity in place to meet its requirements ahead of completion. 

Enquiries

Marston's PLC

Ralph Findlay, Chief Executive Officer

Andrew Andrea, Chief Financial and Corporate Development Officer

Tel: 01902 329516

 

J.P. Morgan Cazenove (Financial Adviser, Sponsor and Joint Corporate Broker to the Company)

James Mitford/Anastasia Volnova/Jonty Edwards

Tel: 020 7742 4000

 

Numis (Joint Corporate Broker to the Company)

Jonathan Wilcox/Alasdair Abram

Tel: 020 7260 1000

 

Instinctif Partners

Justine Warren/Matthew Smallwood

Tel: 020 7457 2010/2005

 

Cautionary statement

This announcement is not intended to, and does not constitute, or form part of, any offer to sell or an invitation to purchase or subscribe for any securities or a solicitation of any vote or approval in any jurisdiction. The information contained in this announcement is not for release, publication or distribution to persons in any jurisdiction where to do so might constitute a violation of local securities laws or regulations.

Important Information relating to financial advisers

J.P. Morgan Securities plc (which conducts its U.K. investment banking activities as J.P. Morgan Cazenove) ("J.P. Morgan Cazenove"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively as sponsor and financial adviser to Marston's plc and for no one else in connection with the Transaction and will not be responsible to anyone other than Marston's PLC for providing the protections afforded to clients of J.P. Morgan Cazenove or for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKNBPKBKDPOB
Date   Source Headline
2nd Oct 20172:48 pmRNSTotal Voting Rights
29th Sep 201710:27 amRNSDirector/PDMR Shareholding
8th Sep 20172:20 pmRNSDirector/PDMR Shareholding
5th Sep 201711:55 amRNSDirectorate Change
1st Sep 20171:47 pmRNSTotal Voting Rights
26th Jul 20177:00 amRNSTrading Update
11th Jul 20178:41 amRNSBlock listing Interim Review
5th Jul 20174:18 pmRNSDirector/PDMR Shareholding
4th Jul 20179:04 amRNSDirector/PDMR Shareholding
28th Jun 20174:03 pmRNSDirector/PDMR Shareholding
22nd Jun 20173:06 pmRNSDirector/PDMR Shareholding
20th Jun 20172:13 pmRNSDirector/PDMR Shareholding
20th Jun 20177:01 amRNSDirector Declaration
2nd Jun 20174:45 pmRNSCompletion of Acquisition of Charles Wells
25th May 20173:12 pmRNSHolding(s) in Company
22nd May 20173:19 pmRNSTotal Voting Rights
18th May 20172:42 pmRNSDirector/PDMR Shareholding
18th May 201712:00 pmRNSResults of Placing
18th May 20177:00 amRNSProposed Placing
18th May 20177:00 amRNSAcquisition
18th May 20177:00 amRNSInterim Results
18th Apr 20172:31 pmRNSNotice of Revised Interim Results Reporting Date
3rd Apr 20171:40 pmRNSTotal Voting Rights
20th Mar 20177:00 amRNSNew Bank Facility
1st Mar 201711:56 amRNSTotal Voting Rights
22nd Feb 20172:30 pmRNSHolding(s) in Company
1st Feb 201711:41 amRNSTotal Voting Rights
25th Jan 201711:49 amRNSResult of AGM
24th Jan 20177:00 amRNSAGM Trading Update
19th Jan 201712:02 pmRNSHolding(s) in Company
10th Jan 20172:26 pmRNSBlock listing Interim Review
3rd Jan 20172:21 pmRNSTotal Voting Rights
19th Dec 20164:39 pmRNSDirector/PDMR Shareholding
16th Dec 20165:00 pmRNSAnnual Financial Report
13th Dec 20167:00 amRNSBoard Appointment
1st Dec 201612:11 pmRNSTotal Voting Rights
28th Nov 20163:04 pmRNSDirector/PDMR Shareholding
28th Nov 20163:02 pmRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSPreliminary Results
1st Nov 20162:46 pmRNSTotal Voting Rights
12th Oct 20167:00 amRNSYear-End Trading Update
3rd Oct 20162:54 pmRNSTotal Voting Rights
21st Sep 20162:04 pmRNSDirector/PDMR Shareholding
21st Sep 20162:02 pmRNSDirector Declaration
21st Sep 20167:00 amRNSDirectorate Change
5th Sep 20163:23 pmRNSDirector/PDMR Shareholding
1st Sep 20163:18 pmRNSDirector/PDMR Shareholding
1st Sep 20163:08 pmRNSTotal Voting Rights
27th Jul 20167:00 amRNSTrading Update
11th Jul 201611:24 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.